GSK3B-DT and liver cancer: Liver cancer patients with high levels of GPNCA expression also showed poor DFS (HR = 1.493, 95% CI, 1.068–2.088, p = 0.01) (Fig. 4H) and RFS (HR = 2.515, 95% CI, 1.383–4.573, p = 0.003) (Fig. 4I).